Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Metabolic factors associated with risk of renal cell carcinoma.

Häggström C, Rapp K, Stocks T, Manjer J, Bjørge T, Ulmer H, Engeland A, Almqvist M, Concin H, Selmer R, Ljungberg B, Tretli S, Nagel G, Hallmans G, Jonsson H, Stattin P.

PLoS One. 2013;8(2):e57475. doi: 10.1371/journal.pone.0057475. Epub 2013 Feb 28.

2.

Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).

Strohmaier S, Edlinger M, Manjer J, Stocks T, Bjørge T, Borena W, Häggström C, Engeland A, Nagel G, Almquist M, Selmer R, Tretli S, Concin H, Hallmans G, Jonsson H, Stattin P, Ulmer H.

PLoS One. 2013;8(1):e54242. doi: 10.1371/journal.pone.0054242. Epub 2013 Jan 23.

3.

Prospective study on metabolic factors and risk of prostate cancer.

Häggström C, Stocks T, Ulmert D, Bjørge T, Ulmer H, Hallmans G, Manjer J, Engeland A, Nagel G, Almqvist M, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P.

Cancer. 2012 Dec 15;118(24):6199-206. doi: 10.1002/cncr.27677. Epub 2012 Oct 22.

4.

Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).

Ulmer H, Bjørge T, Concin H, Lukanova A, Manjer J, Hallmans G, Borena W, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stattin P, Tretli S, Kleiner A, Stocks T, Nagel G.

Gynecol Oncol. 2012 May;125(2):330-5. doi: 10.1016/j.ygyno.2012.01.052. Epub 2012 Feb 10.

PMID:
22330614
5.

Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).

Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P.

Int J Cancer. 2011 Apr 15;128(8):1890-8. doi: 10.1002/ijc.25521.

6.

Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.

Borena W, Strohmaier S, Lukanova A, Bjørge T, Lindkvist B, Hallmans G, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Häggström C, Tretli S, Concin H, Jonsson H, Stattin P, Ulmer H.

Int J Cancer. 2012 Jul 1;131(1):193-200. doi: 10.1002/ijc.26338. Epub 2011 Sep 8.

7.

Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).

Lindkvist B, Almquist M, Bjørge T, Stocks T, Borena W, Johansen D, Hallmans G, Engeland A, Nagel G, Jonsson H, Selmer R, Diem G, Häggström C, Tretli S, Stattin P, Manjer J.

Cancer Causes Control. 2013 Jan;24(1):107-16. doi: 10.1007/s10552-012-0096-6. Epub 2012 Nov 13.

PMID:
23149498
8.

Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).

Nagel G, Bjørge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Häggström C, Engeland A, Johansen D, Kleiner A, Selmer R, Ulmer H, Tretli S, Jonsson H, Concin H, Stattin P, Lukanova A.

Br J Dermatol. 2012 Jul;167(1):59-67. doi: 10.1111/j.1365-2133.2012.10974.x. Epub 2012 Apr 24.

PMID:
22530854
9.

Pooled cohort study on height and risk of cancer and cancer death.

Wirén S, Häggström C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S, Stocks T, Stattin P.

Cancer Causes Control. 2014 Feb;25(2):151-9. doi: 10.1007/s10552-013-0317-7. Epub 2013 Oct 31.

10.

Occupation as a risk factor for renal cell cancer: a nationwide, prospective epidemiological study.

Mariusdottir E, Ingimarsson JP, Jonsson E, Einarsson GV, Aspelund T, Gudnason V, Gudbjartsson T.

Scand J Urol. 2016 Jun;50(3):181-5. doi: 10.3109/21681805.2016.1151460. Epub 2016 Mar 21.

PMID:
26999634
11.

Metabolic syndrome and esophageal and gastric cancer.

Lin Y, Ness-Jensen E, Hveem K, Lagergren J, Lu Y.

Cancer Causes Control. 2015 Dec;26(12):1825-34. doi: 10.1007/s10552-015-0675-4. Epub 2015 Oct 8.

PMID:
26450604
12.

A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.

Borena W, Edlinger M, Bjørge T, Häggström C, Lindkvist B, Nagel G, Engeland A, Stocks T, Strohmaier S, Manjer J, Selmer R, Tretli S, Concin H, Hallmans G, Jonsson H, Stattin P, Ulmer H.

PLoS One. 2014 Feb 21;9(2):e89368. doi: 10.1371/journal.pone.0089368. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102291.

13.

The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study.

Lindblad P, Wolk A, Bergström R, Persson I, Adami HO.

Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):631-9.

14.

Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.

Joh HK, Giovannucci EL, Bertrand KA, Lim S, Cho E.

J Natl Cancer Inst. 2013 May 15;105(10):726-32. doi: 10.1093/jnci/djt082. Epub 2013 Apr 8.

15.

Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can).

Nagel G, Concin H, Bjørge T, Rapp K, Manjer J, Hallmans G, Diem G, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stocks T, Tretli S, Ulmer H, Stattin P, Lukanova A.

Ann Oncol. 2011 Jun;22(6):1339-45. doi: 10.1093/annonc/mdq597. Epub 2010 Oct 21.

PMID:
20966183
16.

Intake of fiber and fiber-rich plant foods is associated with a lower risk of renal cell carcinoma in a large US cohort.

Daniel CR, Park Y, Chow WH, Graubard BI, Hollenbeck AR, Sinha R.

Am J Clin Nutr. 2013 May;97(5):1036-43. doi: 10.3945/ajcn.112.045351. Epub 2013 Mar 20.

17.

Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.

Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM.

Int J Cancer. 2013 Feb 1;132(3):625-34. doi: 10.1002/ijc.27639. Epub 2012 Jun 20.

18.

Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.

Sellin JN, Reichardt W, Bishop AJ, Suki D, Rhines LD, Settle SH, Brown PD, Li J, Rao G, Chang EL, Tatsui CE.

J Neurosurg Spine. 2015 Jan;22(1):52-9. doi: 10.3171/2014.9.SPINE1482.

PMID:
25360530
19.

Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.

Zitt E, Pscheidt C, Concin H, Kramar R, Lhotta K, Nagel G.

PLoS One. 2016 Aug 18;11(8):e0161376. doi: 10.1371/journal.pone.0161376. eCollection 2016.

20.

Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women.

Bjørge T, Tretli S, Engeland A.

Am J Epidemiol. 2004 Dec 15;160(12):1168-76.

PMID:
15583369

Supplemental Content

Support Center